Herman Sanchez - 01 Jul 2021 Form 4 Insider Report for Biostage, Inc. (BSTG)

Role
Director
Signature
/s/ Chad Porter, by power of attorney
Issuer symbol
BSTG
Transactions as of
01 Jul 2021
Transactions value $
$0
Form type
4
Filing time
10 Nov 2021, 19:37:46 UTC
Next filing
01 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSTG Stock Option (right to buy) Award $0 +22,500 $0 22,500 01 Jul 2021 Common Stock, par value $0.01 per share 22,500 $1.35 Direct F1
transaction BSTG Stock Option (right to buy) Award $0 +18,035 +80.16% $0 40,535 01 Jul 2021 Common Stock, par value $0.01 per share 18,035 $1.35 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on October 1, 2021, January 1, 2022, April 1, 2022 and July 1, 2022.
F2 This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, October 1, 2021, January 1, 2022 and April 1, 2022.

Remarks:

This form has been signed under power of attorney.